Page 20 - SaxoCell Annual Report 2021
P. 20
SaxoCell Portrait
SaxoCell stands for the development of new application areas and production methods
for gene and cell therapeutics, so-called "living drugs". SaxoCell channels local
discoveries toward the design and production of cells with precise targets and function
SaxoCell Structure competence in modular industrial scale cell production will secure a sustainable
for safer, more effective clinical therapy. SaxoCell’s path from discovery to clinic and its
economic model for the Saxony region.
SaxoCell will significantly improve regional networking in Saxony in the field of cell
and gene therapy, integrate further partners and initiatives nationwide and close
corresponding gaps in the value chains. In this way, synergy potentials will be raised and
realized, which in turn will greatly increase the visibility of Saxon and nationwide partners
in the field of cell and gene therapy, facilitate access to funding and, through clinical and
regulatory cooperation, accelerate clinical implementation. Through these and other
activities, SaxoCell will thus significantly increase the attractiveness for investments of
national and international companies in this industrial sector and contribute
substantially to the development and further strengthening of an innovative cell and
gene therapy industry in Saxony, Germany.
15
